checkAd
    Startseite > Aktien > Biogen > Nachrichten
    Biogen Aktie
    207,90
     
    EUR
    +0,24 %
    +0,50 EUR
    Letzter Kurs 14:22:25 Tradegate
    206,30
     
    EUR
    49 STK
    Geldkurs 15:19:25
    207,90
     
    EUR
    75 STK
    Briefkurs 15:19:25
    ISIN: US09062X1037 · WKN: 789617 · SYM: IDP · USA ·

    Neueste Nachrichten

    Biogen and Delta Flight Products to Collaborate with Advocates and Patients to Inform the Future of Accessible Air Travel
    13:30 Uhr · globenewswire · Biogen
    NASDAQ: BIIB: Kessler Topaz Meltzer & Check, LLP Notifies Investors of a Securities Class Action Lawsuit Filed Against Biogen Inc.
    01.06.24 · Business Wire (engl.) · Biogen
    Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Biogen Inc. (BIIB) Investors
    31.05.24 · Business Wire (engl.) · Biogen
    Biogen Receives European Commission Approval for QALSODY (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALS
    30.05.24 · globenewswire · Biogen
    INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Biogen Inc. (BIIB) Investors
    30.05.24 · Business Wire (engl.) · Biogen
    The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Biogen Inc. (BIIB) Investors
    30.05.24 · Business Wire (engl.) · Biogen
    BIIB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
    30.05.24 · Business Wire (engl.) · Biogen
    Biogen Inc. Investor Notice: Robbins LLP Reminds Stockholders of the Class Action Against BIIB
    29.05.24 · Business Wire (engl.) · Biogen
    Biotech Report: Biontech (22UA) und Qiagen (QIA) unter Druck
    28.05.24 · Shareribs · AmgenAnzeige
    Biotech Report: Vita34 (V3V) und Qiagen (QIA) behauptet, US-Sektor klettert
    24.05.24 · Shareribs · AmgenAnzeige
    Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Biogen Inc. (BIIB) Investors
    24.05.24 · Business Wire (engl.) · Biogen
    BIIB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
    24.05.24 · Business Wire (engl.) · Biogen